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A B S T R A C T
Questions: In people with chronic obstructive pulmonary disease, does the Manual Diaphragm Release
Technique improve diaphragmatic mobility after a single treatment, or cumulatively? Does the
technique also improve exercise capacity, maximal respiratory pressures, and kinematics of the chest
wall and abdomen? Design: Randomised, controlled trial with concealed allocation, intention-to-treat
analysis, and blinding of participants and assessors. Participants: Twenty adults aged over 60 years with
clinically stable chronic obstructive pulmonary disease. Intervention: The experimental group received
six treatments with theManual DiaphragmRelease Technique on non-consecutive days within a 2-week
period. The control group received sham treatments following the same regimen. Outcome measures:
The primary outcome was diaphragmatic mobility, which was analysed using ultrasonography. The
secondary outcomes were: the 6-minute walk test; maximal respiratory pressures; and abdominal and
chest wall kinematics measured by optoelectronic plethysmography. Outcomes were measured before
and after the ﬁrst and sixth treatments. Results: TheManual Diaphragm Release Technique signiﬁcantly
improved diaphragmatic mobility over the course of treatments, with a between-group difference in
cumulative improvement of 18 mm (95% CI 8 to 28). The technique also signiﬁcantly improved the 6-
minute walk distance over the treatment course, with a between-group difference in improvement of
22 m (95% CI 11 to 32). Maximal expiratory pressure and sniff nasal inspiratory pressure both showed
signiﬁcant acute beneﬁts from the technique during the ﬁrst and sixth treatments, but no cumulative
beneﬁt. Inspiratory capacity estimated by optoelectronic plethysmography showed signiﬁcant
cumulative beneﬁt of 330 ml (95% CI 100 to 560). The effects on other outcomes were non-signiﬁcant
or small. Conclusion: The Manual Diaphragm Release Technique improves diaphragmatic mobility,
exercise capacity and inspiratory capacity in people with chronic obstructive pulmonary disease. This
technique could be considered in the management of people with chronic obstructive pulmonary
disease. Trial registration: NCT02212184. [Rocha T, Souza H, Branda˜o DC, Rattes C, Ribeiro L, Campos
SL, Aliverti A, de Andrade AD (2015) The Manual Diaphragm Release Technique improves
diaphragmatic mobility, inspiratory capacity and exercise capacity in people with chronic
obstructive pulmonary disease: a randomised trial. Journal of Physiotherapy 61: 182–189]
 2015 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Chronic obstructive pulmonary disease (COPD) causes chronic
inﬂammation of the airways and destruction of the lung
parenchyma, which lead to structural changes and dynamic
collapse in the small airways.1 Its most striking feature is
expiratory airﬂow limitation (ie, the ability to perform a complete
exhalation is impaired, causing air trapping and lung hyperinﬂa-
tion).1 The hyperinﬂation causes the diaphragm muscle ﬁbres,
which usually lie vertically in the zone of apposition, to become
more transversely oriented. This makes the diaphragm’s contrac-
tion less effective at raising and expanding the lower rib cage, and
may even lead to a decrease in the transverse diameter of thehttp://dx.doi.org/10.1016/j.jphys.2015.08.009
1836-9553/ 2015 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).lower rib cage during inspiration.2,3 The diaphragm then under-
goes a reduction in the number of sarcomeres to restore its
pressure-generating capacity; however, as a consequence, dia-
phragmatic mobility is reduced. The reduction of diaphragmatic
motion is a major risk factor for increased mortality in people
with COPD.4
The deterioration in airﬂow limitation with COPD progresses
slowly, so most people who present with symptoms of COPD are
elderly.5 Thus, in addition to the parenchymal abnormalities,
musculoskeletal changes inherent to the ageing process contribute
to worsening symptoms in these people.5 These musculoskeletal
changes include increased chest wall stiffness due to the
calciﬁcation of the costal cartilages and costovertebral joints..V. This is an open access article under the CC BY-NC-ND license (http://
Research 183Those changes hinder rib cage expansion, increase the work of
breathing and reduce functional capacity.6,7
Given the interdependent relationship between the respiratory
and musculoskeletal systems, various manual techniques have
been proposed for the treatment of COPD symptoms. A common
goal is increasing themobility of the thoracic structures involved in
respiratory mechanics.8,9 The Manual Diaphragm Release Tech-
nique is an intervention intended to directly stretch the
diaphragmatic muscle ﬁbres, which is described in detail in
textbooks.10,11 Although this technique is widely used in clinical
practice in some regions, it is believed that, to date, there are no
quantitative studies or clinical trials evaluating the effects of this
technique. The present study aimed to evaluate the effects of the
Manual Diaphragm Release Technique on respiratory function of
people with COPD.
Therefore, the research questions for this study were:1. In people with COPD, does the Manual Diaphragm Release
Technique improve diaphragmatic mobility after a single
treatment, or cumulatively?2. D[(Figure_1)TD$FIG]
Figure 1. Manual Diaphragm Release Technique. Source: Authors’ own photo.
With the participant lying supine, the therapist made manual contact (pisiform,
hypothenar region and the last three ﬁngers) with the underside of the costal
cartilages of the seventh to tenth ribs. During the participant’s inspiration, the
therapist pulled gently in a cephalad direction accompanying the elevation
movement of the ribs. During exhalation, the therapist deepened contact toward
the inner costal margin. On subsequent breaths, the therapist sought to gain
traction and smoothly deepen the contact. The manoeuvre was performed in two
sets of 10 deep breaths, with a 1-minute interval between them.oes the technique also improve exercise capacity, maximal
respiratory pressures, and kinematics of the abdomen and chest
wall?
Method
Design
A single-centre, randomised, controlled trial was conducted in
the Physiotherapy Department of the Universidade Federal de
Pernambuco, Brazil, to determine the effects of the Manual
Diaphragm Release Technique in adults with clinically stable
COPD. Eligible participants were randomly allocated to one of two
groups according to a random number table, which was held by a
research associatewhowas not otherwise involved in the study. To
ensure that allocations remained concealed until eligibility and
enrolment were conﬁrmed, the associate did not indicate to the
therapist which group the participant would be allocated to until
immediately before the intervention. Participants who were
randomised to the experimental group received six treatments
with the Manual Diaphragm Release Technique, while the control
group received six sham treatments. Outcomes were measured
before and after the ﬁrst and sixth treatments. The researchers
responsible for outcome measurement and data analysis were not
permitted to know which group each participant belonged to. The
protocol complied with the Declaration of Helsinki.
Participants, therapists and centre
The study’s inclusion criteria were: ex-smokers; clinically
stable (ie, no exacerbation in the previous 6 weeks); aged >
60 years; and post-bronchodilator measurements of forced
expiratory volume in one second (FEV1) < 80% predicted and
FEV1  0.7 of forced vital capacity (FVC).1 The exclusion criteria
were: other cardiopulmonary diseases, body mass index > 30 kg/
m2, previous thoracic surgery, lack of consent, and inability to
understand the verbal commands necessary for the outcome
assessments.
A portable spirometera was used to assess FEV1 and FVC
according to American Thoracic Society/European Respiratory
Society criteria,12 which were interpreted against predicted values
for the Brazilian population.13 Age and gender were also recorded
at baseline.
The interventions were applied by a single investigator, who
had 8 years of experience as a physiotherapist and 3 years of
experience speciﬁcally treating respiratory patients. Participants
were recruited from the local university hospital. The study was
conducted in a dedicated laboratory for cardiopulmonary physio-
therapy research within the Physiotherapy Department.Intervention
Participants in both groups received six treatments, separated
by 1 to 2 days, during a 2-week period. The same therapist
performed the intervention in both groups, in order to ensure
similar application of the experimental and sham interventions.
Participants assigned to the experimental group received the
Manual Diaphragm Release Technique, as shown in Figure 1. The
participant lay supine with relaxed limbs. Positioned at the head of
the participant, the therapist made manual contact with the
pisiform, hypothenar region and the last three ﬁngers bilaterally to
the underside of the seventh to tenth rib costal cartilages, with the
therapist’s forearms aligned toward the participant’s shoulders. In
the inspiratory phase, the therapist gently pulled the points of
contact with both hands in the direction of the head and slightly
laterally, accompanying the elevation of the ribs. During exhala-
tion, the therapist deepened contact toward the inner costal
margin, maintaining resistance. In the subsequent respiratory
cycles, the therapist progressively increased the depth of contact
inside the costal margin. The manoeuvre was performed in two
sets of 10 deep breaths, with a 1-minute interval between them.
In the control group, a sham protocol was applied. Manual
contacts, duration, and positioning of the therapist and participant
were the same as in the experimental group, but the therapist
maintained only light touch with the same anatomical landmarks,
without exerting pressure or traction.14 This was intended to blind
all participants about their group assignment during the study.
Outcome measures
The primary outcome was diaphragmatic mobility and the
secondary outcomes were exercise capacity, maximal respiratory
pressures, and abdominal and chest wall kinematics. Outcomes
were measured in both groups on four occasions: before and
immediately after the ﬁrst treatment session (Pre 1 and Post 1) and
immediately before and after the sixth treatment session (Pre
6 and Post 6). The only exception was exercise capacity, which was
measured at Pre 1 and Pre 6.
Diaphragmatic mobility
To evaluate diaphragmatic mobility, a high-resolution ultra-
soundb with a 3.5 MHz convex transducer was used according to
the protocol suggested by Testa and colleagues.15 Each participant
was verbally instructed to perform an inspiratory capacity
manoeuvre, and each curve corresponding to the diaphragmatic
Rocha et al: Manual Diaphragm Release Technique for COPD184displacement was measured (in mm) immediately after obtaining
the images. The manoeuvres were repeated until ﬁve satisfactory
images were obtained. The ﬁnal value used in the analysis was the
average of the three highest values that did not differ from each
other by more than 10%. All ultrasound assessments were
performed by the same assessor, aiming to reduce evaluation
bias, as recommended by Testa and colleagues.15 Figure 2 shows
the measurement of the diaphragmatic displacement during an
inspiratory capacity manoeuvre performed by one of the
participants.
Exercise capacity
Exercise capacity was measured with the 6-minute walk test,
which was performed in accordance with the American Thoracic
Society criteria,16 at Pre 1 and Pre 6.
Maximal respiratory pressures
Maximum inspiratory and expiratory pressures were obtained
from the residual volume and total lung capacity, respectively,
according to American Thoracic Society/European Respiratory
Society criteria.12 A portable digital manometerc was used to
perform the evaluation. This manometer was also used to assess
each participant’s sniff nasal inspiratory pressure by placing the
nasal plug into one nostril, without contralateral occlusion. Ten
sniff manoeuvres were performed with maximal inspiratory effort
(with 1minute of rest betweenmanoeuvres) and the greatest value
achieved was used in the analysis.17
Optoelectronic plethysmography
Volumes of the chestwall and abdomen, and regional variations
in those volumes with respiratory manoeuvres, were measured by
optoelectronic plethysmographyd. Eighty-nine reﬂective markers
were placed on the participant’s skin using a hypoallergenic
adhesive over speciﬁc anatomical points of the chest wall and
abdomen.18 Changes in chest wall volumes were calculated,
allowing acquisition of total chest wall volume (Vcw) and the
division into three compartments: pulmonary rib cage (Vrcp),
abdominal rib cage (Vrca) and abdomen (Vab).19 These measure-
ments were recorded during quiet breathing, a slow vital capacity
manoeuvre and an inspiratory capacity manoeuvre. The optoelec-
tronic plethysmography was performed with the participant
sitting upright. After the pre-treatment assessment was complete,
the markers on the participant’s back were removed and their
positionsmarked by a non-toxic pen, allowing their replacement in
exactly the same location for the post-treatment assessment.[(Figure_2)TD$FIG]
Figure 2. M-mode diaphragm ultrasonography. Source: Authors’ own photo.
A = gallbladder, B = reference beam for M-mode evaluation, C = diaphragm, D =
positioning of markers for diaphragm displacement measurements, TO =
inspiratory time (s), DO = diaphragmatic displacement (mm), VO = velocity of
displacement (mm/s).Data analysis
The immediate effect of the ﬁrst application of the intervention
for each participant was calculated by subtracting the Pre 1 value
from the Post 1 value, with the average effect then determined as
the mean between-group difference in change, with a 95% CI. The
immediate effect of the sixth application was analysed the same
way (ie, subtract Pre 6 from Post 6 for each participant and
calculate the mean between-group difference and 95% CI). The
cumulative effect of the repeated applications of the interventions
was calculated by subtracting the Pre 1 value from the Pre 6 value
for each participant, and again calculating the mean between-
group difference in changewith a 95% CI. Analysis was by intention
to treat. Correlations between some variables were also assessed
using linear regression analysis.
The sample size was calculated using commercial softwaree
that accepts the anticipated data from each group to determine
sample size. In the absence of published data to guide the
anticipated values, it was decided a priori to calculate the sample
size required for the primary outcome variable (ie, diaphragmatic
mobility) with power (1–b) of 80%, an a of 5%, and data from the
ﬁrst seven experimental-group participants and seven control-
group participants: 88 mm (SD 5) and 62 mm (SD 19), respectively.
The sample size was estimated at 12 (six per group). To account for
possible loss to follow-up, 20 participants were enrolled.
Results
Flow of participants through the study
Figure 3 shows the ﬂow of participants through the study. The
baseline characteristics of the participants are presented in Table 1
and in the ﬁrst two columns of data in Tables 2 and 4. The groups
were well balanced at baseline.
Compliance with the study protocol
One participant, who was allocated to the experimental group,
completelywithdrew from the study after the ﬁrst assessment (Pre
1). All other participants received all scheduled treatments as
allocated by the randomisation process andwere analysed in those
groups (ie, intention-to-treat analysis).
Effect of the Manual Diaphragm Release Technique
Diaphragmatic mobility
The diaphragmatic mobility data of both groups are presented
in Figure 4 and Table 2. The average acute effect during the ﬁrst
treatment session was a between-group difference of 2 mm in
favour of the experimental technique, but this was not statistically
signiﬁcant (95% CI –2 to 6). The average acute effect during the
sixth treatment session was larger, with a between-group
difference of 6 mm, which was statistically signiﬁcant (95% CI
2 to 9). When the cumulative effect of the treatments was
estimated by the change from before the ﬁrst session to before the
sixth session, the between-group difference was 18 mm in favour
of the experimental technique, which was also statistically
signiﬁcant (95% CI 8 to 28). Individual participant data are
presented in Table 3 on the eAddenda.
Exercise capacity
The experimental group showed a mean cumulative improve-
ment on the 6-minute walk test of 15 m (SD 14) from before the
ﬁrst session to before the sixth session, whereas the control group
deteriorated by amean of 6m (SD 6). This equated to a statistically
signiﬁcant between-group difference in change for the 6-minute
walk distance in favour of the experimental group by 22 m (95% CI
11 to 32). Individual participant data are presented in Table 3 on
the eAddenda.
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Excluded (n = 36)
• did not meet inclusion criteria (n = 27)
• declined to participate (n = 9)
Control group
• sham technique as above
• 4 sessions
• 1 to 2 days between 
sessions 
Experimental group
• MDR technique as above
• 4 sessions
• 1 to 2 days between 
sessions
Pre 6
Measured diaphragmatic mobility, exercise capacity, maximal respiratory pressures and OEP
(n = 10) (n = 9)
Control group
• sham technique
• 2 sets x 10 breaths
Experimental group
• MDR technique
• 2 sets x 10 breaths
Post 6
Measured diaphragmatic mobility, maximal respiratory pressures and OEP
(n = 10) (n = 9)
Control group
• sham technique
• 2 sets x 10 breaths
Patients with chronic obstructive 
pulmonary disease contacted (n = 66)
Assessed for eligibility (n = 30)
Measured diaphragmatic mobility, exercise capacity, maximal respiratory pressures and OEP
Randomised (n = 20)
(n = 11) (n = 9)
Pre 1
Experimental group
• MDR technique
• 2 sets x 10 breaths
Post 1 Measured diaphragmatic mobility, maximal respiratory pressures and OEP
(n = 10) (n = 9)
Lost to follow-up
• discontinued (n = 1)
Excluded (n = 10)
• FEV1 > 80% and/or FEV1/FVC > 0.7 (n = 5)
• declined to participate (n = 2)
• misunderstood verbal commands (n = 1)
• recent thoracic surgery (n = 1)
• body mass index > 30 kg/m2 (n = 1)
Figure 3. Design and ﬂow of participants through the trial. MDR = Manual Diaphragmatic Release, OEP = optoelectronic plethysmography.
Research 185Maximal respiratory pressures
The mean between-group difference in change in maximal
inspiratory pressure favoured the experimental group when
analysed as change during the ﬁrst session, change during the sixth
session, and cumulative change over the course of treatments.Table 1
Baseline characteristics of participants.
Characteristic Exp
(n=9)
Con
(n=10)
Age (yr), mean (SD) 71 (6) 71 (5)
Gender, male:female 6:3 8:2
BMI (kg/m2), mean (SD) 26 (3) 24 (4)
FEV1 (%pred), mean (SD) 36 (13) 33 (12)
FVC (%pred), mean (SD) 52 (17) 48 (9)
FEV1/FVC (%), mean (SD) 53 (5) 49 (9)
Exp = experimental group, Con = control group.However, none of these were statistically signiﬁcant. Maximal
expiratory pressure and sniff nasal inspiratory pressure both
showed signiﬁcant acute beneﬁts of theManual DiaphragmRelease
Technique during the ﬁrst and sixth treatments. Neither measure
showeda signiﬁcantbeneﬁtwhen cumulative changewas analysed.
See Table 2, and Table 3 on the eAddenda for individual patient data.
Optoelectronic plethysmography
Optoelectronic plethysmographic estimates of vital capacity
showed a signiﬁcant beneﬁt from the experimental intervention
during the ﬁrst treatment (mean between-group difference in
change 295 ml, 95% CI 151 to 439) and again during the sixth
treatment (249 ml, 95% CI 114 to 383). However, no signiﬁcant
cumulative beneﬁt was observed, as shown in Figure 5. The
estimates of inspiratory capacity showed a signiﬁcant beneﬁt from
the experimental intervention during the ﬁrst treatment (mean
between-group difference in change 237 ml, 95% CI 95 to 380) but
Table 2
Mean (SD) for diaphragmaticmobility andmaximal respiratory pressures for each group,mean (SD) differencewithin groups, andmean (95% CI) difference between groups for acute effect of the ﬁrst session (Post 1minus Pre 1), acute effect of the
sixth session (Post 6 minus Pre 6) and cumulative effect (Pre 6 minus Pre 1).
Outcome Groups Difference within groups Difference between groups
(units) Pre 1 Post 1 Pre 6 Post 6 Post 1 minus
Pre 1
Post 6 minus
Pre 6
Pre 6 minus
Pre 1
Post 1 minus
Pre 1
Post 6 minus
Pre 6
Pre 6 minus
Pre 1
Exp Con Exp Con Exp Con Exp Con Exp Con Exp Con Exp Con Exp minus Con Exp minus Con Exp minus Con
(n=10) (n=9) (n=10) (n=9) (n=10) (n=9) (n=10) (n=9)
Diaphragm
mobility
(mm)
71 (16) 68 (15) 73 (17) 69 (17) 82 (11) 61 (16) 87 (10) 61 (17) 3 (5) 0 (3) 5 (4) –1 (3) 11 (11) –7 (10) 2 (–2 to 6) 6 (2 to 9) 18 (8 to 28)
Maximal
inspiratory
pressure
(cm H2O)
64 (20) 64 (11) 67 (18) 59 (11) 64 (20) 61 (14) 69 (25) 61 (14) 3 (12) –5 (5) 4 (6) 0 (2) 1 (7) –3 (5) 8 (–1 to 17) 4 (0 to 9) 4 (–2 to 10)
Maximal
expiratory
pressure
(cm H2O)
98 (30) 99 (22) 101 (27) 89 (19) 104 (30) 107 (19) 105 (32) 102 (17) 2 (15) –10 (7) 1 (6) –5 (6) 6 (24) 8 (12) 13 (1 to 24) 6 (1 to 12) –2 (–20 to 17)
Sniff nasal
inspiratory
pressure
(cm H2O)
48 (12) 53 (12) 56 (8) 50 (10) 51 (12) 49 (8) 59 (13) 48 (8) 7 (5) –3 (5) 8 (6) –1 (4) 3 (11) –4 (9) 10 (5 to 16) 9 (4 to 14) 6 (–3 to 16)
Exp = experimental group, Con = control group, Pre 1 = before ﬁrst session, Pre 6 = before sixth session, Post 1 = after ﬁrst session, Post 6 = after sixth session.
Table 4
Mean (SD) for optoelectronic plethysmographicmeasures during quiet breathing for each group,mean (SD) differencewithin groups, andmean (95% CI) difference between groups for acute effect of ﬁrst session (Post 1minus Pre 1), acute effect of
sixth session (Post 6 minus Pre 6) and cumulative effect (Pre 6 minus Pre 1).
Outcome Groups Difference within group Difference between groups
(units) Pre 1 Post 1 Pre 6 Post 6 Post 1 minus
Pre 1
Post 6 minus
Pre 6
Pre 6 minus
Pre 1
Post 1 minus
Pre 1
Post 6 minus
Pre 6
Pre 6 minus
Pre 1
Exp Con Exp Con Exp Con Exp Con Exp Con Exp Con Exp Con Exp minus Con Exp minus Con Exp minus Con
(n=10) (n=9) (n=10) (n=9) (n=10) (n=9) (n=10) (n=9)
Vcw (ml) 554 (151) 418 (69) 564 (158) 456 (101) 449 (168) 435 (126) 506 (157) 461 (124) 10 (94) 38 (73) 58 (48) 26 (104) –105 (187) 17 (75) –28 (–110 to 54) 31 (–46 to 108) –122 (–263 to 19)
Vrcp (ml) 144 (66) 102 (41) 143 (79) 107 (42) 102 (65) 112 (42) 134 (66) 113 (52) –2 (47) 5 (13) 32 (27) 1 (24) –42 (45) 10 (17) –7 (–40 to 27) 31 (6 to 56) –52 (–86 to –18)
Vrca (ml) 67 (43) 48 (18) 66 (45) 50 (14) 41 (31) 65 (20) 49 (30) 59 (22) –1 (15) 2 (22) 8 (13) –7 (13) –26 (46) 17 (31) –3 (–21 to 16) 15 (2 to 27) –43 (–86 to –5)
Vab (ml) 344 (92) 272 (102) 355 (99) 303 (138) 307 (102) 262 (129) 323 (97) 293 (140) 11 (62) 31 (72) 16 (32) 31 (89) –37 (136) –10 (62) –21 (–85 to 44) –15 (–79 to 48) –27 (–131 to 77)
Exp = experimental group, Con = control group, Pre 1 = before ﬁrst session, Pre 6 = before sixth session, Post 1 = after ﬁrst session, Post 6 = after sixth session, Vab = volume abdomen, Vcw= total chestwall volume, Vrca = volume abdominal rib cage,
Vrcp = volume pulmonary rib cage.
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Figure 4. Change in diaphragmatic mobility in both groups during the treatment.
Exp = experimental group, Con = control group.
Session 1 = acute effect of ﬁrst treatment session (Post 1 minus Pre 1). Session 6 =
acute effect of sixth treatment session (Post 6 minus Pre 6). Cumulative =
cumulative effect of ﬁrst ﬁve sessions (Pre 6 minus Pre 1). Numerical data are
presented in Table 2.
a mean difference in change 6 mm (95% CI 2 to 9).
b mean difference in change 18 mm (95% CI 8 to 28).
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Figure 6. Change in inspiratory capacity in both groups during the treatment.
Exp = experimental group, Con = control group.
Session 1 = acute effect of ﬁrst treatment session (Post 1 minus Pre 1). Session 6 =
acute effect of sixth treatment session (Post 6 minus Pre 6). Cumulative =
cumulative effect of ﬁrst ﬁve sessions (Pre 6 minus Pre 1). Individual patient data
are presented in Table 3.
a mean difference in change 237 ml (95% CI 95 to 380).
b mean difference in change 330 ml (95% CI 100 to 560).
Research 187not during the sixth treatment. Despite this, a signiﬁcant
cumulative beneﬁt of 330 ml (95% CI 100 to 560) was observed,
as shown in Figure 6. When compartmental volumes were
analysed during the inspiratory capacity manoeuvre, there were
no signiﬁcant between-group differences in Vcw or Vab. Although
Vrcp and Vrca each showed an acute beneﬁt from the experimental
intervention during the sixth session, they each also showed
deterioration due to the experimental intervention when the
cumulative effect was analysed, see the last two columns of
Table 4. Although statistically signiﬁcant, these could be clinically
trivial effects because the 95% CI around themean estimates do not
exclude effects of 18 ml or smaller. When data from the ﬁrst and
sixth sessions were pooled, the acute improvements in diaphrag-
matic mobility and abdominal compartment volume during a
session moderately correlated (r = 0.45), as shown in Figure 7. The
individual participant data for all the optoelectronic plethysmo-
graphic outcomes are presented in Table 3 on the eAddenda.
Discussion
In the present study, the Manual Diaphragm Release Technique
produced statistically signiﬁcant improvements in diaphragmatic
mobility, 6-minute walking distance and inspiratory capacity in
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Figure 5. Change in vital capacity in both groups during the treatment.
Exp = experimental group, Con = control group.
Session 1 = acute effect of ﬁrst treatment session (Post 1 minus Pre 1). Session 6 =
acute effect of sixth treatment session (Post 6 minus Pre 6). Cumulative =
cumulative effect of ﬁrst ﬁve sessions (Pre 6 minus Pre 1). Individual patient data
are presented in Table 3.
a mean difference in change 295 ml (95% CI 151 to 439).
b mean difference in change 249 ml (95% CI 114 to 383).people with COPD. Immediate but non-cumulative beneﬁts were
also noted in vital capacity, maximum expiratory pressure and
sniff nasal inspiratory pressure. The improvement in diaphrag-
matic mobility showed moderate correlation with abdominal
volume during inspiratory capacity manoeuvres.
It is not possible to compare many of the present results with
other published results because the evaluation methods used in
the present study have not previously been applied to the
experimental intervention. Indeed, the Manual Diaphragm
Release Technique has undergone little research at all. The lack
of studies on manual therapy in people with COPD was
highlighted by Heneghan and colleagues in their systematic
review,20 which also revealed widespread non-concealment of
allocation and lack of blinding in the studies that have been
published. The use of these procedures in the present study is
therefore one of its strengths.
The acute effects of the experimental intervention might seem
to be an important outcome. However, the analysis of the
cumulative effect may be more relevant because it reﬂects a
sustained effect developing over the course of treatment. The lack
of reference values for diaphragmatic mobility in a large
population of healthy individuals weakens the comparison
between the present study treatment outcomes against normative
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Figure 7. Relationship between changes in diaphragmatic mobility and inspiratory
capacity within a single treatment (session 1 or session 6) in the trial.
Exp = experimental group, Con = control group.
Rocha et al: Manual Diaphragm Release Technique for COPD188data. However, if it is considered that the mean diaphragmatic
mobility in 38 healthy individuals presented by Testa and
colleagues was 79 mm (SD 14),15 the cumulative effect of the
repeated administration of the Manual Diaphragm Release
Technique (ie, approximately 18 mm) seemed surprisingly to be
enough to bring people with COPD close to the normal range of
diaphragmatic mobility.
Given this beneﬁcial effect on diaphragmatic mobility, it can be
hypothesised that the manual action on the underside of the last
four costal cartilages allows the traction of the lower rib cage in a
cranial direction and that the manual compression of the tissues in
the area of insertion of the anterior costal diaphragm ﬁbres
lengthens the diaphragm in its insertional zone. At the moment,
this is only a speculative hypothesis, not supported by direct
measurements. This hypothesis, however, could be tested in future
studies, again by ultrasound, placing a larger probe at the
midaxillary line in order to perform a quantitative evaluation of
the diaphragm’s zone of apposition, as previously suggested.21
According to Aliverti and colleagues,21 in healthy people,
accurate continuous measurements of abdominal volume varia-
tions allow estimation of instantaneous diaphragm displacement
during quiet breathing, accounting for 89% of the variability of
diaphragm displacement in the zone of apposition, whereas rib
cage displacement accounts for less than 1%. More recently, Priori
and colleagues22 showed similar results in people with COPD,
where change in Vab accounted on average for 76% of diaphrag-
matic displacement in the zone of apposition during quiet
breathing in the seated position. The results of the present study,
as shown in Figure 7, regarding the relationship between
abdominal displacement (assessed by optoelectronic plethysmog-
raphy) and diaphragmatic motion (assessed by ultrasound) during
the inspiratory capacity manoeuvre conﬁrm that these two
measures of diaphragmatic displacement were correlated, al-
thoughwith a smaller regression coefﬁcient. Thismight be because
in the previous studies it was possible to record both measure-
ments simultaneously, with diaphragmatic motion being assessed
by placing the ultrasound probe on the lateral rib cage, thus
allowing visibility of the markers. In the present study, diaphrag-
matic motion was assessed by placing the ultrasound probe on the
anterior subcostal abdominal surface. It was therefore not possible
to achieve simultaneous measurements and this probably led to
the lower regression coefﬁcient. Nevertheless, the signiﬁcant
effects of the intervention on diaphragmatic motion were
corroborated by two independent methods of evaluation.
To date, no studies have evaluated changes in tidal volume by
studying thoraco-abdominal kinematics in people with COPD after
manual therapy techniques. Wilkens and colleagues observed that
despite the structural remodelling of the diaphragm in this
pathology, its ability to generate tidal volume remains preserved.23
Despite this preserved capacity to generate not only tidal volume,
but also tension,24 of the diaphragm muscle in people with COPD,
the compensatory adjustments that have been reported in the
literature in terms ofmuscle remodelling25may not ensure normal
diaphragmatic function in the presence of the persistent altera-
tions in its geometry and coupling with the chest wall.26 The
present hypothesis was that direct intervention on the diaphragm
and the chest wall, irrespective of residual diaphragm muscle
ability to generate force, can partially reverse muscle remodelling,
namely attenuating the shortening of the length of sarcomeres.
In people with obstructive lung disease, inspiratory capacity
represents the operating limits for tidal volume expansion during
the increased ventilation of exercise. Moreover, this variable can
predict the peak symptom-limited oxygen uptake and is a
determinant of exercise performance in these people.27 The
comparison of inspiratory capacity values between the present
participants and healthy individuals would be biased by the
physiopathology of this disease. Thus, the cumulative improve-
ment of inspiratory capacity after the treatment (ie, approximately
330 ml) should be considered together with the functional gain in
exercise capacity. The between-group difference in 6-minute walkdistance in favour of the experimental group was slightly higher
than the value presented as the smallest worthwhile effect of
pulmonary rehabilitation in people with COPD.28 According to
MacNamara and colleagues, from the patient’s perspective, an
increase of 20 m on the 6-minute walk test can make the costs,
risks and inconvenience of 8 weeks of pulmonary rehabilitation
worthwhile.28 Given that the Manual Diaphragm Release Tech-
nique is a more passive treatment administered in shorter sessions
over 2 weeks, people with COPD would presumably consider the
22 m improvement worthwhile.
The cumulative analysis in this study demonstrated some
substantial effects, but this may only represents effects maintained
since the preceding treatment (ie, 1 or 2 days earlier). If the effects
observed in this study were shown to be sustained for a longer
period, a combination of manual therapy with pulmonary rehabili-
tation programs may be appropriate, as previously performed by
Zanotti and colleagues.29 In their study, the group that received
rehabilitation with manual therapy showed signiﬁcantly greater
beneﬁts in residual volume and 6-minute walk distance. Unfortu-
nately, the authors did not describe the manual techniques used.29
The acute changes in maximal respiratory pressures may be
related to a learning effect because no signiﬁcant cumulative effect
of the treatment on those variables (as determined by the change
from Pre 1 to Pre 6) was found. Therefore, despite the increase in
diaphragmatic mobility, the intervention did not appear to lead to
any sustained improvement in the pressure generation of the
muscle. This suggests that the proposed intervention has low
inﬂuence over the diaphragm’s contractile properties.
A limitation of the present study was that the study cohort was
not sufﬁcient to allow the effect of the experimental intervention to
be analysed in different subgroups such as age or disease severity.
However, the study cohort was representative of many people with
COPD and subgroup analyses could be examined in a larger study.
Given that chest wall stiffness results from calciﬁcation of the
costovertebral joints, intervertebral discs and costal cartilages in
the elderly, causing the decline in vital capacity,6 it might be
hypothesised that the increased overall chest wall expansion
observed in the experimental group, as seen in the increased vital
capacity, is partly due to the effects imposed by this technique (ie,
traction of the lower rib cage in a cranial direction). During
repeated respiratory cycles, the technique may have promoted the
mobilisation of rib cage joints and increased the range of motion of
the entire rib cage. Nevertheless, it is difﬁcult to comment about
the effects of the proposed manual release technique on the chest
wall as no studies are reported in the literature. Therefore, another
hypothesis, to be conﬁrmed in future studies, is that the technique
acts both on diaphragm length and lower rib cage compliance.
In conclusion, the present study has demonstrated that the
Manual Diaphragm Release Technique improves diaphragmatic
mobility, inspiratory capacity and exercise capacity, suggesting that
it should be considered in the management of people with COPD.What is already known on this topic: People with chronic
obstructive pulmonary disease (COPD) have impairment of
expiratory airflow, lung hyperinflation, flattening of the dia-
phragm and reduced exercise capacity. Many people with
COPD are older adults, so the natural reduction in chest wall
mobility with age may exacerbate their respiratory limitation.
What this study adds: The Manual Diaphragm Release
Technique applies manual pressure under the costal margin,
with the intention of stretching the lower thoracic cage and the
insertional fibresof the anterior diaphragm.Six sessionsof this
technique lead to cumulative improvements in diaphragmatic
mobility, inspiratory capacity and exercise capacity.Footnotes: a Micro Loop 8, Micromedical, England. b SonoaceR3,
Samsung Medison, South Korea. c MVD 3001, MDI Ltd, Brazil. d
Optoelectronic plethysmograph, BTS Bioengineering, Italy. e G
Power 3.1.3, Heinrich-Heine-Universita¨t Du¨sseldorf, Germany.
Research 189eAddenda: Table 3 can be found online at doi:10.1016/j.jphys.
2015.08.009.
Ethics approval: The Universidade Federal de Pernambuco
Ethics Committee approved this study. All participants gave
written informed consent before data collection began.
Competing interests: Nil.
Source(s) of support: This study was supported by grants from
Foundation for Science and Technology of the state of Pernambuco
(FACEPE) - APQ 0234-4.08/13 and CNPQ Edital Universal 482069/
2012.
Acknowledgements: Coordenac¸a˜o de Aperfeic¸oamento de
Pessoal de Nı´vel Superior (CAPES) and Conselho Nacional de
Desenvolvimento Cientı´ﬁco e Tecnolo´gico (CNPQ).
Provenance: Not invited. Peer-reviewed.
Correspondence: Arme`le Dornelas de Andrade, Department of
Physical Therapy, Universidade Federal de Pernambuco- UFPE,
Recife, Brazil. Email: armeledornelas@hotmail.com
References
1. GOLD. Global Initiative for Chronic Obstructive Lung Disease [homepage on the
Internet]. 2011. Available from: www.goldcopd.org. Accessed December 26, 2012.
2. Yamaguti W, Paulin E, Shibao S, Chammas M, Salge JM, Ribeiro M, et al. Air
trapping: the major factor limiting diaphragm mobility in chronic obstructive
pulmonary disease patients. Respirology. 2008;13:138–144.
3. Aliverti A, Quaranta M, Chakrabarti B, Albuquerque LP, Calverley PM. Paradoxical
movement of the lower ribcage at rest and during exercise in COPD patients. Eur
Respir J. 2009;33:49–60.
4. Yamaguti WPdS. Paulin E, Salge JM, Chammas MC, Cukier A, de Carvalho CRFD.
Disfunc¸a˜o diafragma´tica e mortalidade em pacientes portadores de DPOC. J Bras
Pneumol. 2009;35:1174–1181.
5. Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest. 2009;135:
173–180.
6. Hochhegger B, DeMeireles GP, Irion K, Zanetti G, Garcia E, Moreira J, et al. The chest
and aging: radiological ﬁndings. J Bras Pneumol. 2012;38:656–665.
7. Soyuer F, S¸enol V. Functional outcome and depression in the elderly with or
without fatigue. Arch Gerontol Geriatr. 2010;53:e164–e167.
8. Chaitow L, Bradley D, Gilbert C. Multidisciplinary approaches to breathing pattern
disorders. 1st ed. London: Churchill Livingstone; 2002:142.
9. DiGiovanna E, Schiowitz S, Dowling D. In: Somers D, ed. In: An Osteopathic
Approach to Diagnosis and Treatment. 3rd ed. Philadelphia: Lippincott Williams
& Wilkins; 2005:404.
10. Ricard F, Salle´ J-L. Tratado de Osteopatia. 3rd ed. Madrid, Spain: Panamericana;
2009:135.11. de Coster M, Pollaris A. Osteopatı´a Visceal. 2nd ed. Madrid, Spain: Paidotribo;
2005:38.
12. American Thoracic Society/European Respiratory Society. ATS/ERS Statement on
Respiratory Muscle Testing. Am J Respir Crit Care Med. 2002;166:518–624.
13. Pereira C, Sato T, Rodrigues S. New reference values for forced spirometry in white
adults in Brazil. J Bras Pneumol. 2007;33:397–406.
14. Licciardone JC, Russo DP. Blinding protocols, treatment credibility, and expectan-
cy: methodologic issues in clinical trials of osteopathic manipulative treatment.
J Am Osteopath Assoc. 2006;106:457–463.
15. Testa A, Soldati G, Giannuzzi R, Berardi S, Portale G, Silveri N. Ultrasound m-mode
assessment of diaphragmatic kinetics by anterior transverse scanning in healthy
subjects. Ultrasound Med Biol. 2011;37:44–52.
16. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk
Test. Am J Respir Crit Care Med. 2002;166:111–117.
17. Severino FG, Resqueti VR, Bruno SS, Azevedo IG, Vieira RHG, Fregonezi GAF.
Comparac¸a˜o entre o manovacuoˆmetro nacional e o importado para medida da
pressa˜o inspirato´ria nasal. Rev Bras Fisioter. 2010;14:426–431.
18. Aliverti A, Pedotti A. Opto-electronic plethysmography. Monaldi Arch Chest Dis.
2003;59:12–16.
19. Cala SJ, Kenyon CM, Ferrigno G, Carnevali P, Aliverti A, Pedotti A, et al. Chest wall
and lung volume estimation by optical reﬂectance motion analysis. J Appl Physiol.
1996;81:2680–2689.
20. Heneghan NR, Adab P, Balanos GM, Jordan RE. Manual therapy for chronic
obstructive airways disease: A systematic review of current evidence. Man Ther.
2012;17:507–518.
21. Aliverti A, Ghidoli G, Dellaca RL, Pedotti A, Macklem PT. Chest wall kinematic
determinants of diaphragm length by optoelectronic plethysmography and ultra-
sonography. J Appl Physiol. 2003;94:621–630.
22. Priori R, Aliverti A, Albuquerque A, Quaranta M, Albert P, Calverley PMA. The effect
of posture on asynchronous chest wall movement in COPD. J Appl Physiol.
2013;114:1066–1075.
23. Wilkens H, Weingard B, Lo Mauro A, Schena E, Pedotti A, Sybrecht GW, et al.
Breathing pattern and chest wall volumes during exercise in patients with cystic
ﬁbrosis, pulmonary ﬁbrosis and COPD before and after lung transplantation.
Thorax. 2010;65:808–814.
24. Similowski T, Yan S, Gauthier AP, Macklem PT, Bellemare F. Contractile properties
of human diaphragm during chronic hyperinﬂation. N Engl J Med. 1991;325:
917–923.
25. Clanton TL, Levine S. Respiratory muscle ﬁber remodeling in chronic hyperinﬂa-
tion: dysfunction or adaptation? J Appl Physiol. 2009;107:324–335.
26. De Troyer A. Effect of hyperinﬂation on the diaphragm. Eur Respir J. 1997;10:
708–713.
27. O’Donnell DE, Laveneziana P. Physiology and consequences of lung hyperinﬂation
in COPD. Eur Respir Rev. 2006;15:61–67.
28. McNamara RJ, Elkins MR, Ferreira ML, Spencer LM, Herbert RD. Smallest worth-
while effect of land-based and water-based pulmonary rehabilitation for COPD.
Eur Respir J Open Res. 2015;1:1–8.
29. Zanotti E, Berardinelli P, Bizzarri C, Civardi A, Manstretta A, Rossetti S, et al.
Osteopathic manipulative treatment effectiveness in severe chronic obstructive
pulmonary disease: a pilot study. Complement Ther Med. 2012;20:16–22.
